Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

09 Apr 2020 --- As gut microbes can affect allergic immune responses, drinking green tea rich in Flavonifractor plautii (FP) bacteria may be able to suppress the T-helper-2 (Th2)... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 Apr 2020 --- US-based snack brand This Saves Lives has launched its second children’s snack line, Kids Krispy Kritter Treats, which are school-safe and are free from... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Apr 2020 --- A booming application genre for probiotics is the gut-brain axis, with certain psychobiotics supported by research as having a positive effect on stress-related gut... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

02 Apr 2020 --- Royal DSM has completed its €765 million (US$826 million) acquisition of Glycom, which is a major supplier of human milk oligosaccharides (HMOs). DSM states... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

01 Apr 2020 --- The term “probiotic” risks overextension when discussing microbes in fermented foods. This was flagged during a NutritionInsight webinar, called... Read More

trans